Formerra will supply Foster® medical compounds across Europe, strengthening access to advanced polymer solutions for healthcare applications.
Formerra and GEON® Performance Solutions announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra’s current distribution of these materials in North and South Americas, enabling Formerra to now support customers who need the same product in all regions.
Following GEON’s January 2025 acquisition of Foster, the agreement builds on Formerra’s long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.
“Bringing Foster’s medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments,” said Kelly Wessner, Vice President, Key Accounts, Formerra. “Building on the momentum of our Americas partnership, we’re excited to extend these proven solutions to European customers who demand the highest standards in medical device materials.”
With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radioopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.
Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world’s most dynamic medical device markets,” said Arthur Adams, Chief Commercial Officer, GEON. “This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally.”
Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.